Ecolab (ECJ) AI Stock Analysis
Ecolab
(XETRA:ECJ)
No summary available
Ecolab (ECJ) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 88.35B
- Dividend Yield
- 0.91%
- Average Volume (3M)
- 53
- Price to Earnings (P/E)
- 42.5
- Beta (1Y)
- 0.63
- Revenue Growth
- 4.02%
- EPS Growth
- 0.99%
- Country
- Germany
- Employees
- 48,000
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
Ecolab Business Overview & Revenue Model
Company Description
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Gl...
Ecolab Earnings Call Summary
The call was strongly positive. Ecolab reported accelerating organic sales and operating income growth, broad-based business outperformance, strong momentum in Life Sciences, Digital, Pest and Global High-Tech, and confidence in achieving its 2027 growth and margin commitments. The principal challenges were persistent commodity inflation, a declining Institutional market, Middle East-related headwinds, M&A-related amortization and interest costs, and variability in near-term margins and High-Tech quarterly growth.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For 2027, Ecolab expects organic sales growth at the upper end of its 5% to 7% target, adjusted operating income margin to reach the 20%, and adjusted EPS growth to meet or exceed its long-term adjusted EPS growth target of 12% to 15%; underlying earnings growth is expected to be mid-teens type of growth, with roughly 5 percentage point headwind in the first half and a 5 percentage point tailwind in the second half, while first-half volume is expected to be 1% to 2% and pricing 5% to 6%, followed by second-half volume of 2% to 3% and pricing a bit lower. Life Sciences is expected to deliver 10% to 12% top line growth and reach 30% operating income margin in the next few years; Global High-Tech is expected to grow more than 25% annually, reach $4 billion in sales by 2030 and deliver 25% operating income margin; pricing is expected to remain 5% to 6% through the fourth quarter and probably the first half of next year, while DPC is assumed to stay at a high level till the end of next year.
Ecolab Risk Analysis
Ecolab disclosed 24 risk factors in its most recent earnings report. Ecolab reported the most risks in the "Legal & Regulatory" category.
Latest Risks Added
0 New RisksEcolab Peers Comparison
Overall Rating
IOSP73Outperform
HWKN69Neutral
ASH61Neutral
SCL61Neutral
KWR60Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 73Outperform | $2.44B | 14.20 | 10.41% | 2.22% | 4.73% | ― | |
| 69Neutral | $3.18B | 37.67 | 15.86% | 0.49% | 9.02% | 3.18% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 61Neutral | $3.34B | 849.33 | 0.21% | 2.18% | 2.08% | ― | |
| 61Neutral | $1.56B | 371.84 | 0.36% | 2.24% | 10.02% | -90.50% | |
| 60Neutral | $2.57B | 27.99 | 7.02% | 1.31% | 8.68% | ― |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:ECJ | Ecolab | 277.70 | 57.78 | 26.27% | |
| ASH | Ashland Global Holdings, Inc. | 76.44 | 27.52 | 56.25% | |
| HWKN | Hawkins Inc | 155.97 | 29.92 | 23.74% | |
| IOSP | Innospec | 80.65 | 8.05 | 11.08% | |
| KWR | Quaker Chemical | 157.30 | 27.15 | 20.86% | |
| SCL | Stepan Company | 70.65 | 29.16 | 70.28% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.